[D-Pro4,D-Trp7,9] Substance P (4-11) Reference: HY-P3803 [D-Pro4,D-Trp7,9] Substance P (4-11) is a potent antagonist of Substance P (HY-P0201). [D-Pro4,D-Trp7,9] Substance P (4-11) decreases plasma aldosterone (ALDO) concentration.
Reltecimod Reference: HY-P1698 Reltecimod (AB-103) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs).
[Tyr8,Nle11] Substance P Reference: HY-P3933 [Tyr8,Nle11] Substance P is a Substance P (HY-P0201) analog. Substance P is a peptide mainly secreted by neurons and is involved in many biological processes, including nociception and inflammation.
Somatostatin-28 (1-14) Reference: HY-P1499 Somatostatin-28 (1-14) is an N-terminal fragment of the neuropeptide somatostatin-28.
DL-Threonine methyl ester hydrochloride Reference: HY-W042057 DL-Threonine methyl ester hydrochloride is a threonine derivative.
C-Reactive Protein (CRP) (174-185) Reference: HY-P1823 C-Reactive Protein (CRP) 174-185 is the 174-185 fragment of C-Reactive Protein. C-Reactive Protein (CRP), the prototypic marker of inflammation, is a cardiovascular risk marker and may promote atherogenesis.